TScan Therapeutics VP of Finance resigns; CFO Amello named principal accounting officer

TScan Therapeutics, Inc.

Leiden Dworak resigns as VP of Finance and principal accounting officer, effective April 10, 2026.
No disagreements between Dworak and TScan regarding operations, policies, or practices.
CFO Jason A. Amello appointed as principal accounting officer, effective same date.
Amello receives no additional compensation for assuming the principal accounting officer role.
Amello's background is incorporated by reference from TScan's May 2025 proxy statement.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.